CSIMarket


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc 's Working Capital Ratio

MRNA's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




MRNA Working Capital Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities Change 575.71 % 5368.71 % 6176.76 % 42480.85 % 15523 %
Y / Y Current Assets Change 275.29 % 292.21 % 836.29 % 1499395 % 99877.95 %
Working Capital Ratio MRQ 1.35 1.24 1.39 1.43 2.43
Overall Ranking # 3434 # 3810 # 3326 # 3093 # 2152
Seq. Current Liabilities Change 12.64 % 4.65 % 92.48 % 197.84 % 811.59 %
Seq. Current Assets Change 22.39 % -6.27 % 85.82 % 76.06 % 27.91 %



Working Capital Ratio third quarter 2021 Comment
Moderna Inc 's Current Assets grew by 22.39 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Moderna Inc 's Working Capital Ratio to 1.35, Working Capital Ratio remained below Moderna Inc average.

Within Biotechnology & Pharmaceuticals industry 205 other companies have achieved higher Working Capital Ratio than Moderna Inc in third quarter 2021. While Working Capital Ratio total ranking has improved so far to 3434, from total ranking in previous quarter at 3810.

Explain Working Capital Ratio
Where is MRNA most successful ?
Working Capital Ratio MRNA on the trailing twelve month basis
Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 206
Healthcare Sector # 880
Overall Market # 3434


Working Capital Ratio Statistics
High Average Low
17.3 1.44 0.01
(Jun 30 2020)   (Sep 30 2017)




Financial Statements
Moderna Inc 's Current Liabilities $ 9,957 Millions Visit MRNA's Balance sheet
Moderna Inc 's Current Assets $ 13,425 Millions Visit MRNA's Balance sheet
Source of MRNA's Sales Visit MRNA's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Working Capital RatioSep 30 2021 MRQ Current AssetsSep 30 2021 MRQ Current Liabilities
Blue Biofuels Inc   3.60 $ 1.467  Millions$ 0.407  Millions
Genocea Biosciences Inc   3.44 $ 50.614  Millions$ 14.704  Millions
Sangamo Therapeutics Inc   3.39 $ 447.396  Millions$ 131.898  Millions
Cyanotech Corp  3.30 $ 15.358  Millions$ 4.647  Millions
Emergent Biosolutions Inc   3.04 $ 1,111.500  Millions$ 365.400  Millions
Chromadex Corporation  2.97 $ 52.835  Millions$ 17.770  Millions
Axon Enterprise inc   2.96 $ 1,123.820  Millions$ 379.890  Millions
Avantor Inc   2.70 $ 3,564.600  Millions$ 1,320.100  Millions
Repligen Corp  2.65 $ 910.854  Millions$ 343.911  Millions
Pactiv Evergreen Inc   2.61 $ 2,068.000  Millions$ 791.000  Millions
Neuronetics Inc   2.53 $ 119.447  Millions$ 47.193  Millions
Surgalign Holdings Inc   2.46 $ 136.079  Millions$ 55.236  Millions
Cytomx Therapeutics Inc   2.42 $ 240.998  Millions$ 99.772  Millions
Sab Biotherapeutics Inc   2.39 $ 0.771  Millions$ 0.322  Millions
Aerie Pharmaceuticals Inc   2.34 $ 275.952  Millions$ 118.128  Millions
Reynolds Consumer Products Inc   2.22 $ 1,041.000  Millions$ 468.000  Millions
Integrated Biopharma Inc  2.21 $ 16.984  Millions$ 7.701  Millions
Coherus Biosciences inc   2.10 $ 673.039  Millions$ 320.348  Millions
Agenus Inc  2.05 $ 308.401  Millions$ 150.131  Millions
Gilead Sciences Inc   2.03 $ 13,991.000  Millions$ 6,877.000  Millions
Biocryst Pharmaceuticals Inc  1.89 $ 252.743  Millions$ 133.608  Millions
Hydrofarm Holdings Group Inc   1.88 $ 222.459  Millions$ 118.569  Millions
Aptevo Therapeutics Inc   1.82 $ 58.873  Millions$ 32.380  Millions
Aziyo Biologics inc   1.74 $ 39.254  Millions$ 22.510  Millions
Intelgenx Technologies Corp   1.73 $ 13.989  Millions$ 8.096  Millions
Biogen Inc   1.70 $ 7,162.300  Millions$ 4,211.600  Millions
Iteos Therapeutics Inc   1.69 $ 914.137  Millions$ 542.228  Millions
Protalix Biotherapeutics inc   1.67 $ 71.224  Millions$ 42.764  Millions
Amgen Inc   1.64 $ 24,380.000  Millions$ 14,842.000  Millions
Immunitybio inc   1.44 $ 94.452  Millions$ 65.408  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STAF's Profile

Stock Price

STAF's Financials

Business Description

Fundamentals

Charts & Quotes

STAF's News

Suppliers

STAF's Competitors

Customers & Markets

Economic Indicators

STAF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071